Elisabeth Menschel Selected Research

Bendamustine Hydrochloride

9/2018

High-dose Bendamustine-EAM followed by autologous stem cell rescue results in long-term remission rates in lymphoma patients, without renal toxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elisabeth Menschel Research Topics

Disease

1	Neoplasms (Cancer) 01/2022
1	Exanthema (Rash) 04/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2021
1	Hodgkin Disease (Hodgkin's Disease) 09/2018
1	Lymphoma (Lymphomas) 09/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2018
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 09/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2018

Drug/Important Bio-Agent (IBA)

1	CPX-351IBA 04/2021
1	Melphalan (Alkeran)FDA LinkGeneric 09/2018
1	Carmustine (FIVB)FDA Link 09/2018
1	Bendamustine Hydrochloride FDA Link 09/2018
1	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2018
1	Etoposide (VP 16)FDA LinkGeneric 09/2018

Therapy/Procedure

1	Precision Medicine 01/2022
1	Therapeutics 01/2022
1	Stem Cell Transplantation 09/2018
1	Transplantation 09/2018
1	BEAM regimen 09/2018